Related Experiment Video
Updated: Mar 13, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Refractory necrotizing scleritis successfully treated with adalimumab
Lola E Lawuyi1, Avinash Gurbaxani2
1, Gate 17, Villa 970 Al Raha Gardens, Abu Dhabi, United Arab Emirates. Lola27law@yahoo.co.uk.
Abstract:
Necrotizing scleritis is the most severe and destructive form of scleritis with vision-threatening sequelae. It is divided into with inflammation and without inflammation (scleromalacia perforans). Adalimumab is a tumour necrosis factor (TNF)-inhibiting anti-inflammatory medication licensed for the treatment of rheumatoid and psoriatic arthritis, ankylosing spondylitis and inflammatory bowel disease (in the USA). We report two cases of necrotizing scleritis successfully treated with adalimumab.

